著者: LiangEmily C, SidanaSurbhi

原題: Managing side effects: guidance for use of immunotherapies in multiple myeloma.

著者: FugereTyler, BaltzAlan, MukherjeeAkash, GaddamMamatha, VarmaAnkur, VeeraputhiranMuthu, Gentille SanchezCesar Giancarlo

原題: Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity.

著者: MartinsFrederico Rajão, AzevedoAndré Costa, GanhãoSara, AguiarFrancisca, RodriguesMariana, BritoIva

原題: Anakinra and hepatotoxicity in pediatric rheumatology: a case series.

著者: PuccettiMatteo, ParianoMarilena, StincardiniClaudia, WojtyloPaulina, SchoubbenAurelie, NunziEmilia, RicciMaurizio, RomaniLuigina, GiovagnoliStefano

原題: Pulmonary drug delivery technology enables anakinra repurposing in cystic fibrosis.

著者: BaverezClara, GrallMaximilien, Gerfaud-ValentinMathieu, De GailSarah, BelotAlexandre, PerpointThomas, WeberEmmanuelle, ReynaudQuitterie, SèvePascal, JamillouxYvan

原題: Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases.

著者: KarabulutYusuf, GezerHalise Hande, ÖzNuran, Esenİrfan, DuruözMehmet Tuncay

原題: Real-life data on tapering or discontinuation of canakinumab therapy in patients with familial Mediterranean fever.

著者: KostikMikhail M, IsupovaEugenia A, BelozerovKonstantin, LikhachevaTatyana S, SuspitsinEvgeny N, RaupovRinat, MasalovaVera V, ChikovaIrina A, DubkoMargarita F, KalashnikovaOlga V, ChasnykVyacheslav G, CronRandy Q

原題: Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis.

著者: MilotaTomáš, MalcováHana, StřížováZuzana, CebecauerováDita, HorváthRudolf

原題: Current treatment options for monogenic periodic fever syndromes - the role of interleukin 1 inhibitors.

著者: BindoliSara, GiolloAlessandro, GalozziPaola, DoriaAndrea, SfrisoPaolo

原題: Hyperinflammation after anti-SARS-CoV-2 mRNA/DNA vaccines successfully treated with anakinra: Case series and literature review.

著者: Lo PrestiSaberio, ElajamiTarec K, ReyaldeenReza, AnthonyChris, ImazioMassimo, KleinAllan L

原題: Emerging Therapies for Recurrent Pericarditis: Interleukin-1 inhibitors.

著者: ImazioMassimo, LazarosGeorge, GattornoMarco, LeWinterMartin, AbbateAntonio, BrucatoAntonio, KleinAllan

原題: Anti-interleukin-1 agents for pericarditis: a primer for cardiologists.

著者: AtasNuh, ErogluGulsah Atbiner, SodanHulya Nur, OzturkBeyza Olcay, BabaogluHakan, SatisHasan, KaradenizHazan, GulerAslihan Avanoglu, SalmanReyhan Bilici, GokerBerna, OzturkMehmet Akif, HaznedarogluSeminur, TufanAbdurrahman

原題: Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients.

著者: SingbartlKai, RosenthalAllison, LeisJose, PatelBhavesh, SenAyan

原題: Novel Use of Extracorporeal Blood Purification for Treatment of Severe, Refractory Neurotoxicity After Chimeric Antigen Receptor T-Cell Therapy-A Case Report.

著者: DoaréElise, RobinFrançois, RacapéHélène, Le MélédoGuillaume, OrioneCharles, GuggenbuhlPascal, GoupillePhilippe, GervaisElisabeth, DernisEmmanuelle, BouvardBéatrice, MarhadourThierry, CoiffierGuillaume, SarauxAlain

原題: Features and Outcomes of Microcrystalline Arthritis Treated by Biologics: A Retrospective Study.

著者: YamanakaGaku, IshidaYu, KanouKanako, SuzukiShinji, WatanabeYusuke, TakamatsuTomoko, MorichiShinichiro, GoSoken, OanaShingo, YamazakiTakashi, KawashimaHisashi

原題: Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy.

著者: BehlTapan, MehtaKeshav, SehgalAayush, SinghSukhbir, SharmaNeelam, AhmadiAmirhossein, AroraSandeep, BungauSimona

原題: Exploring the role of polyphenols in rheumatoid arthritis.

著者: KyriazopoulouEvdoxia, PanagopoulosPeriklis, MetallidisSymeon, DalekosGeorge N, PoulakouGaryphallia, GatselisNikolaos, KarakikeEleni, SaridakiMaria, LoliGeorgia, StefosAggelos, PrasianakiDanai, GeorgiadouSarah, TsachouridouOlga, PetrakisVasileios, TsiakosKonstantinos, KosmidouMaria, LygouraVassiliki, DareiotiMaria, MilionisHaralampos, PapanikolaouIlias C, AkinosoglouKarolina, MyrodiaDimitra-Melia, GravvaniAreti, StamouAliki, GkavogianniTheologia, KatriniKonstantina, MarantosTheodoros, TrontzasIoannis P, SyrigosKonstantinos, ChatzisLoukas, ChatzisStamatios, VechlidisNikolaos, AvgoustouChristina, ChalvatzisStamatios, KyprianouMiltiades, van der MeerJos Wm, Eugen-OlsenJesper, NeteaMihai G, Giamarellos-BourboulisEvangelos J

原題: An open label trial of anakinra to prevent respiratory failure in COVID-19.

著者: RuscittiPiero, BerardicurtiOnorina, CiprianiPaola, GiacomelliRoberto,

原題: Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial.

著者: MalcovaHana, StrizovaZuzana, MilotaTomas, StrizIlja, SedivaAnna, CebecauerovaDita, HorvathRudolf

原題: IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives.

著者: Plasencia-GarcíaBeatriz Oda, Rodríguez-MenéndezGonzalo, Rico-RangelMaría Isabel, Rubio-GarcíaAna, Torelló-IserteJaime, Crespo-FacorroBenedicto

原題: Drug-drug interactions between COVID-19 treatments and antipsychotics drugs: integrated evidence from 4 databases and a systematic review.

著者: UgurluSerdal, ErgezenBilgesu, EgeliBugra Han, SelviOguzhan, OzdoganHuri

原題: Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience.

著者: FerraraGiovanna, GianiTeresa, CaparelloMaria Costanza, FarellaCarla, GamaleroLisa, CimazRolando

原題: Anakinra for Treatment-Resistant Kawasaki Disease: Evidence from a Literature Review.

著者: ErdenAbdulsamet, OzdemirBahar, KarakasOzlem, MutluNevzat Mehmet, IzdesSeval, KalemAyse Kaya, BilirYeşim Aybar, AypakAdalet, AkinciEsragul, GunerRahmet, KucuksahinOrhan

原題: Evaluation of 17 patients with COVID-19 pneumonia treated with anakinra according to HScore, SOFA, MuLBSTA, and Brescia-COVID respiratory severity scale (BCRSS) scoring systems.

著者: HuetThomas, BeaussierHélène, VoisinOlivier, JouveshommeStéphane, DauriatGaëlle, LazarethIsabelle, SaccoEmmanuelle, NaccacheJean-Marc, BézieYvonnick, LaplancheSophie, Le BerreAlice, Le PavecJérôme, SalmeronSergio, EmmerichJoseph, MouradJean-Jacques, ChatellierGilles, HayemGilles

原題: Anakinra for severe forms of COVID-19: a cohort study.

著者: CauchoisRaphaël, KoubiMarie, DelarbreDavid, ManetCécile, CarvelliJulien, BlascoValery Benjamin, JeanRodolphe, FoucheLouis, BornetCharleric, PaulyVanessa, MazodierKarin, PestreVincent, JarrotPierre-André, DinarelloCharles A, KaplanskiGilles

原題: Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19.

著者: KurtTuba, AydınFatma, Nilüfer TekgözP, SezerMüge, UncuNermin, Çelikel AcarBanu

原題: Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience.

著者: UgurluSerdal, ErgezenBilgesu, EgeliBugra Han, SelviOguzhan, OzdoganHuri

原題: Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean fever.